The DOI matches its Crossref record; the references it cites are not checked yet.
The association between inflammation-related biomarkers and the subtypes of cancer-related cognitive impairment in colorectal cancer patients: A latent profile analysis
Abstract
PURPOSE Cancer-related cognitive impairment (CRCI) has garnered considerable attention, yet limited research has delved into nuanced distinctions among varying degrees of CRCI in colorectal cancer survivors. This study aimed to identify distinct subgroups based on the patterns of CRCI, assess the heterogeneity among different subgroups, and investigate the potential correlations between the subgroups of CRCI and inflammation-related biomarkers. METHODS 268 colorectal cancer patients were enrolled in this cross-sectional study, followed by the Functional Assessment of Cancer Therapy-Cognitive Function. The determination of CRCI subgroups was accomplished by the latent profile analysis (LPA). The effects of inflammation-related biomarkers on CRCI were examined using the binary logistic regression analysis. The receiver operating characteristic (ROC) curves assessed the diagnostic efficacy of inflammation-related biomarkers. RESULTS Two latent profiles were identified: CRCI (n = 64, 23.88%) and non-CRCI (n = 204, 76.12%). Independent factors for CRCI in colorectal cancer patients were SIRI (OR = 3.248, 95%CI [1.197-8.807], P = 0.021) and ALI (OR = 0.962, 95%CI [0.937-0.989], P = 0.005). The areas under the curve (AUCs) for SIRI and ALI in predicting CRCI were 0.781 and 0.774, with the optimal cut-off values being 0.70 and 37.04, respectively. CONCLUSIONS Colorectal cancer patients exhibited divergent cognitive performance profiles, categorized into two subgroups based on LPA. SIRI and ALI were identified as independent factors for CRCI, demonstrating strong diagnostic accuracy. These two inflammation-related biomarkers may potentially be novel indicators to identify and manage the development of CRCI among colorectal cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists haven’t been fetched yet
Cited by 5
Research works printed but not linked: 47
- Allegra, 2020, Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology, Expert Rev. Hematol., 13, 393, 10.1080/17474086.2020.1738213 · DOI
- Ashraf-Ganjouei, 2020, The association between systemic inflammation and cognitive performance in healthy adults, J. Neuroimmunol., 345, 10.1016/j.jneuroim.2020.577272 · DOI
- Bauer, 2022, Latent variable and clustering methods in intersectionality research: systematic review of methods applications, Soc. Psychiatr. Psychiatr. Epidemiol., 57, 221, 10.1007/s00127-021-02195-6 · DOI
- Bozdogan, 1987, Model selection and Akaike's Information Criterion (AIC): the general theory and its analytical extensions, Psychometrika, 52, 345, 10.1007/BF02294361 · DOI · Paper page
- Carragher, 2009, Subtypes of depression in a nationally representative sample, J. Affect. Disord., 113, 88, 10.1016/j.jad.2008.05.015 · DOI · Paper page
- Cerulla Torrente, 2020, Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy, J Cancer Surviv, 14, 464, 10.1007/s11764-020-00870-2 · DOI
- Chan, 2021, Systematic review of cognitive impairment in colorectal cancer survivors who received chemotherapy, Oncol. Nurs. Forum, 48, 634, 10.1188/21.ONF.634-647 · DOI
- Cheung, 2013, Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in asian patients with breast cancer, Value Health, 16, 1001, 10.1016/j.jval.2013.06.017 · DOI
- Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322 · DOI · Paper page
- Dyk, 2019, vol. 4
- Fuca, 2021, The pan-immune-inflammation value in patients with metastatic melanoma receiving first-line therapy, Targeted Oncol., 16, 529, 10.1007/s11523-021-00819-0 · DOI
- Gideon, 1978, Estimating the dimension of a model, Ann. Stat., 6, 461
- Guven, 2022, The association between the pan-immune-inflammation value and cancer prognosis: a systematic review and meta-analysis, Cancers, 14, 2675, 10.3390/cancers14112675 · DOI · Paper page
- He, 2022, G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors, FEBS Open Bio, 12, 1268, 10.1002/2211-5463.13445 · DOI
- Howard, 2017, Variable-centered, person-centered, and person-specific approaches, Organ. Res. Methods, 21, 846, 10.1177/1094428117744021 · DOI · Paper page
- Jang, 2022, Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy, Neuron, 110, 3288, 10.1016/j.neuron.2022.08.009 · DOI
- Kusunoki, 2020, Advanced lung cancer inflammation index predicts outcomes of patients with colorectal cancer after surgical resection, Dis. Colon Rectum, 63, 1242, 10.1097/DCR.0000000000001658 · DOI
- Lange, 2019, Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors, Ann. Oncol., 30, 1925, 10.1093/annonc/mdz410 · DOI · Paper page
- Lee, 2019, Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer, Cancer Med., 8, 564, 10.1002/cam4.1956 · DOI
- Liu, 2022, Diagnostic value of carcinoembryonic antigen combined with multi-inflammatory cell ratios in colorectal cancer, Dis. Markers, 2022, 10.1155/2022/4889616 · DOI
- Llinas-Regla, 2017, The Trail making test, Assessment, 24, 183, 10.1177/1073191115602552 · DOI · Paper page
- Luo, 2022, Type 2 diabetes mellitus-associated cognitive dysfunction: advances in potential mechanisms and therapies, Neurosci. Biobehav. Rev., 137, 10.1016/j.neubiorev.2022.104642 · DOI · Paper page
- Luo, 2023, The high burden of symptoms associated with cognitive impairment in lung cancer patients: a latent class analysis, Asia Pac J Oncol Nurs, 10, 10.1016/j.apjon.2023.100200 · DOI
- Mandelblatt, 2014, Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?, J. Clin. Oncol., 32, 1909, 10.1200/JCO.2013.54.2050 · DOI · Paper page
- Mayo, 2018, Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping review, BMJ Open, 8, 10.1136/bmjopen-2017-017578 · doi:10.1136/bmjopen-2017-017578
- Mayo, 2021, Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group, Support. Care Cancer, 29, 2821
- Nguyen, 2020, Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases, EMBO Mol. Med., 12, 10.15252/emmm.202012075 · DOI · Paper page
- Nylund, 2007, Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study, Struct. Equ. Model., 14, 535, 10.1080/10705510701575396 · DOI · Paper page
- Oppegaard, 2022, Higher stress and symptom severity are associated with worse depressive symptom profiles in patients receiving chemotherapy, Eur. J. Oncol. Nurs., 58, 10.1016/j.ejon.2021.102031 · DOI
- Oppegaard, 2022, Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: a scoping review, Crit. Rev. Oncol. Hematol., 180, 10.1016/j.critrevonc.2022.103822 · DOI
- Orszaghova, 2021, Long-term cognitive dysfunction in cancer survivors, Front. Mol. Biosci., 8, 10.3389/fmolb.2021.770413 · DOI · Paper page
- Pépin, 2021, Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment, Nephrol. Dial. Transplant., 37, ii23, 10.1093/ndt/gfab262 · DOI
- Piehl, 2022, Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment, Cell, 185, 5028, 10.1016/j.cell.2022.11.019 · DOI · Paper page
- Qi, 2016, A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy, Cancer, 122, 2158, 10.1002/cncr.30057 · DOI · Paper page
- Rick, 2022, Cancer-related cognitive dysfunction, Onkologe, 28, 231, 10.1007/s00761-021-01075-7 · DOI
- Root, 2022, Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: the Thinking and Living with Cancer Study, Breast Cancer Res. Treat., 194, 413, 10.1007/s10549-022-06623-2 · DOI
- Ryan, 2021, Normative performance of older individuals on the Hopkins Verbal Learning Test-Revised (HVLT-R) according to ethno-racial group, gender, age and education level, Clin. Neuropsychol., 35, 1174, 10.1080/13854046.2020.1730444 · DOI
- Santisteban, 2023, Hypertension, neurovascular dysfunction, and cognitive impairment, Hypertension, 80, 22, 10.1161/HYPERTENSIONAHA.122.18085 · DOI · Paper page
- Schietroma, 2022, Systemic inflammation response index (SIRI) as predictor of anastomotic leakage after total gastrectomy for gastric cancer, Surg Oncol, 43, 10.1016/j.suronc.2022.101791 · DOI
- Sclove, 1987, Application of model-selection criteria to some problems in multivariate analysis, Psychometrika, 52, 333, 10.1007/BF02294360 · DOI · Paper page
- Sharma, 2022, Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet Gastroenterol Hepatol, 7, 627, 10.1016/S2468-1253(22)00044-9 · DOI · Paper page
- Shibutani, 2019, The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study, BMC Cancer, 19, 241, 10.1186/s12885-019-5468-9 · DOI
- Su, 2022, Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in depression: a meta-analysis, J. Affect. Disord., 308, 375, 10.1016/j.jad.2022.04.038 · DOI · Paper page
- Wefel, 2015, Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults, CA A Cancer J. Clin., 65, 123
- Wefel, 2011, International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, Lancet Oncol., 12, 703, 10.1016/S1470-2045(10)70294-1 · DOI · Paper page
- Yamamoto, 2021, Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients, Int. J. Mol. Sci., 22, 8002, 10.3390/ijms22158002 · DOI · Paper page
- Zhang, 2021, The activity of daily living (ADL) subgroups and health impairment among Chinese elderly: a latent profile analysis, BMC Geriatr., 21, 30, 10.1186/s12877-020-01986-x · DOI · Paper page
Metadata
- Authors
- Sun, J., Dong, Y., Wang, D., Yang, Y., Zhou, Z., Zhu, M., Wang, T., & Teng, L.
- Venue
- European Journal of Oncology Nursing
- Publisher
- Elsevier BV
- Published
- 2024-02
- Volume
- 68
- Pages
- 102493
- ISSN
- 1462-3889
- Cited by
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- National Natural Science Foundation of China (82172583)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The association between inflammation-related biomarkers and the subtypes of cancer-related cognitive impairment in colorectal cancer patients: A latent profile analysis. https://app.cochat.ai/papers/10.1016/j.ejon.2023.102493
- The paper
- Sun, J., Dong, Y., Wang, D., Yang, Y., Zhou, Z., Zhu, M., Wang, T., & Teng, L. (2024). The association between inflammation-related biomarkers and the subtypes of cancer-related cognitive impairment in colorectal cancer patients: A latent profile analysis. European Journal of Oncology Nursing. https://doi.org/10.1016/j.ejon.2023.102493
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.